Here's an older PR from Inergetics, but one that's
Post# of 1040
Posted On: 03/22/2015 9:22:27 PM
Here's an older PR from Inergetics, but one that's vital to the CBD products that will be released in the near future and worth reading again.
Inergetics Discovers Unique Combination of Cannabinoids for New Product Line as it Exits Phase II of R&D and Prepares for Final Development Phase
Breakthrough Further Illustrates Inergetics' Position as Nutraceutical Innovator
PR Newswire
Inergetics, Inc. September 24, 2014 10:00 AM
NEWARK, N.J., Sept. 24, 2014 /PRNewswire/ -- Inergetics, Inc. (NRTI), a leading developer of nutritional supplements, today announced that it has identified and procured a non-cannabis source of an important cannabinoid that will be incorporated into its initial "first to market" combination cannabinoid product line to provide additional synergistic benefits in terms of overall efficacy and absorption.
"With direction from our Scientific/Medical Advisory Board and strategic relationships we have developed internationally, Inergetics has sourced and procured a novel non-cannabis cannabinoid to work side-by-side with CBD," states Chief Science Officer Carl Germano, RD, CNS, CDN. "This additional cannabinoid from a non-cannabis source is a perfect companion to our CBD ingredient as it targets receptors in the body that help control inflammation and pain signaling. By bringing these two important cannabinoids together, our first nutraceutical CBD product line is capable of feeding the body's own endocannabinoid system while delivering greater efficacy and helping to enhance absorption."
"I'm pleased that our R&D efforts in cannabinoid science have led us to this unique and promising combination of phytocannabinoids that we expect will offer effective treatment for various pain-related ailments," states Michael James, CEO of Inergetics. "Our team continues to research various CBD-related formulas and we are confident our research will continue to yield exciting results that we can bring to the market to address a wide array of symptoms."
Introducing non-cannabis cannabinoids to its CBD product line is a market leading innovation in the emerging and evolving cannabinoid space. Inergetics will be launching its new CBD product line in medical marijuana dispensaries in 2015.
Continued updates on the CBD product initiative and the Scientific/Medical Advisory Board will be made available at http://www.inergetics.com/cbd-initiative/.
http://finance.yahoo.com/news/inergetics-disc...00668.html
Inergetics Discovers Unique Combination of Cannabinoids for New Product Line as it Exits Phase II of R&D and Prepares for Final Development Phase
Breakthrough Further Illustrates Inergetics' Position as Nutraceutical Innovator
PR Newswire
Inergetics, Inc. September 24, 2014 10:00 AM
NEWARK, N.J., Sept. 24, 2014 /PRNewswire/ -- Inergetics, Inc. (NRTI), a leading developer of nutritional supplements, today announced that it has identified and procured a non-cannabis source of an important cannabinoid that will be incorporated into its initial "first to market" combination cannabinoid product line to provide additional synergistic benefits in terms of overall efficacy and absorption.
"With direction from our Scientific/Medical Advisory Board and strategic relationships we have developed internationally, Inergetics has sourced and procured a novel non-cannabis cannabinoid to work side-by-side with CBD," states Chief Science Officer Carl Germano, RD, CNS, CDN. "This additional cannabinoid from a non-cannabis source is a perfect companion to our CBD ingredient as it targets receptors in the body that help control inflammation and pain signaling. By bringing these two important cannabinoids together, our first nutraceutical CBD product line is capable of feeding the body's own endocannabinoid system while delivering greater efficacy and helping to enhance absorption."
"I'm pleased that our R&D efforts in cannabinoid science have led us to this unique and promising combination of phytocannabinoids that we expect will offer effective treatment for various pain-related ailments," states Michael James, CEO of Inergetics. "Our team continues to research various CBD-related formulas and we are confident our research will continue to yield exciting results that we can bring to the market to address a wide array of symptoms."
Introducing non-cannabis cannabinoids to its CBD product line is a market leading innovation in the emerging and evolving cannabinoid space. Inergetics will be launching its new CBD product line in medical marijuana dispensaries in 2015.
Continued updates on the CBD product initiative and the Scientific/Medical Advisory Board will be made available at http://www.inergetics.com/cbd-initiative/.
http://finance.yahoo.com/news/inergetics-disc...00668.html
(0)
(0)